 |
|
Rendra et al. Clinical-grade human skin-derived ABCB5+ mesenchymal stromal cells exert anti-apoptotic and anti-inflammatory effects in vitro and modulate mRNA expression in a cisplatin-induced kidney injury murine model. Front Immunol 2023;14:1228928  |
|
|
|
Schröder et al. Drug regulatory-compliant validation of a qPCR assay for bioanalysis studies of a cell therapy product with a special focus on matrix interferences in a wide range of organ tissues. Cells 2023;12:1788 |
|
|
|
Dieter et al. ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa. Cytotherapy 2023;25:782-788 |
|
|
|
Yan et al. ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo. Stem Cell Res Ther 2023;14:24 |
|
|
|
Niebergall-Roth et al. Skin-derived ABCB5+ mesenchymal stem cells for high-medical-need inflammatory diseases: from discovery to entering clinical routine. Int J Mol Sci 2023;24:66 |
|
|
|
Nardozi et al. Potential therapeutic effects of long-term stem cell administration: impact on the gene profile and kidney function of PKD/Mhm (Cy/+) rats. J Clin Med 2022;11:2061 |
|
|
|
Kiritsi et al. Clinical trial of ABCB5-positive mesenchymal stem cells for recessive dystrophic epidermolysis bullosa. JCI Insight 2021;6:e151922 |
|
|
|
Harrell et al. The role of Interleukin 1 receptor antagonist in mesenchymal stem cell-based tissue repair and regeneration. BioFactors. 2020;46:263-275 |
|
|
|
Jiang et al. Mesenchymal Stem Cells Adaptively Respond to Environmental Cues Thereby Improving Granulation Tissue Formation and Wound Healing. Front Cell Dev Biol 2020;8:697 |
|
|
|
Riedl et al. ABCB5+ dermal mesenchymal stromal cells with favorable skin homing and local immunomodulation for Recessive Dystrophic Epidermolysis Bullosa treatment. Stem Cells 2021;39:897-903 |
|
|
|
Ballikaya et al. Process data of allogeneic ex vivo-expanded ABCB5+ mesenchymal stromal cells for human use: Off-the-shelf GMP-manufactured donor-independent ATMP. Stem Cell Res Ther 2020;11:482 |
|
|
|
Klicks et al. A novel spheroid-based co-culture model mimics loss of keratinocyte differentiation, melanoma cell invasion, and drug-induced selection of ABCB5-expressing cells. BMC Cancer 2019;19:402 |
|
|
|
Hartwig et al. Human skin derived ABCB5+ stem cell injection improves liver disease parameters in Mdr2KO mice. Arch Toxicol 2019;93:2645-2660 |
|
|
|
Vander Beken et al., Newly Defined ATP-Binding Cassette Subfamily B Member 5 Positive Dermal Mesenchymal Stem Cells Promote Healing of Chronic Iron-Overload Wounds via Secretion of Interleukin-1 Receptor Antagonist. Stem Cells 2019;37:1057–1074 |
|
|
|
Tappenbeck et al. In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials. Cytotherapy 2019;21:546-560 |
|
|
|
Tietze et al. Assessment of the hepatocytic differentiation ability of human skin-derived ABCB5+ stem cells. Exp Cell Res 2018;369:335-347 |
|
|
|
Borchers et al. Detection of ABCB5 tumour antigen-specific CD8+ T cells in melanoma patients and implications for immunotherapy. Clin Exp Immunol 2017;191:74-83 |
|
|
|
Schatton et al. ABCB5 identifies immunoregulatory dermal cells. Cell Rep. 2015 Sep 8; 12(10): 1564–1574 |
|
|
|
Ksander et al. ABCB5 is a limbal stem cell gene required for corneal development and repair. Nature 2014;511:353-357 |
